ResearcherShanghai Medical College of Fudan UniversityActive in the last 2 years
Xinzhe Zhu
Matched on OpenAlex author ID A5058803337. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 7
2023: 1 paper · 2024: 2 papers
Papers 3
- Pancreatic Cancer: An Exocrine Tumor With Endocrine Characteristics. Co-author DOI 10.1097/sla.0000000000006168↗
- Efficacy of vitamin C on chemotherapy-related anemia in pancreatic cancer: study protocol for a randomized controlled trial. First author DOI 10.1186/s13063-024-08345-w↗
- Hyperglycemia predicts adverse prognosis in advanced pancreatic cancer patients. Co-author DOI 10.1007/s12020-022-03196-4↗
Closest collaborators
The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Zhiwen Xiao · 3 shared papers, 2023–2024 · strength 0.66
- Paper Efficacy of vitamin C on chemotherapy-related anemia in pancreatic cancer: study protocol for a randomized controlled t… DOI 10.1186/s13063-024-08345-w↗
- Paper Hyperglycemia predicts adverse prognosis in advanced pancreatic cancer patients. DOI 10.1007/s12020-022-03196-4↗
- Paper Pancreatic Cancer: An Exocrine Tumor With Endocrine Characteristics. DOI 10.1097/sla.0000000000006168↗
- Guopei Luo · 3 shared papers, 2023–2024 · strength 0.66
- Paper Efficacy of vitamin C on chemotherapy-related anemia in pancreatic cancer: study protocol for a randomized controlled t… DOI 10.1186/s13063-024-08345-w↗
- Paper Hyperglycemia predicts adverse prognosis in advanced pancreatic cancer patients. DOI 10.1007/s12020-022-03196-4↗
- Paper Pancreatic Cancer: An Exocrine Tumor With Endocrine Characteristics. DOI 10.1097/sla.0000000000006168↗
- Quanxing Ni · 2 shared papers, 2023–2024 · strength 0.41
- Xianjun Yu · 2 shared papers, 2023–2024 · strength 0.41
- Xinyue Wang · 1 shared paper, 2024 · strength 0.26
- Huaxiang Xu · 1 shared paper, 2023 · strength 0.20
- Jianfeng Luo · 1 shared paper, 2024 · strength 0.20
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.